[Reply].
作者信息
Lellig Katja, Buchner Alexander, Stief Christian
出版信息
Urologe A. 2015 Jun;54(6):870.
PMID:26280043
Abstract
摘要
相似文献
1
[Reply].
Urologe A. 2015 Jun;54(6):870.
2
[Active surveillance of low risk prostate cancer].
Urologe A. 2015 Jun;54(6):869-70. doi: 10.1007/s00120-015-3804-5.
3
Diagnostic challenges of clonal heterogeneity in prostate cancer.
J Clin Oncol. 2015 Mar 1;33(7):e38-40. doi: 10.1200/JCO.2013.50.3540. Epub 2014 Mar 17.
4
Will active surveillance for clinically localized prostate cancer survive in the era of individualized medicine?
Eur Urol. 2014 Aug;66(2):186-7. doi: 10.1016/j.eururo.2014.04.020. Epub 2014 May 13.
5
Prostate cancer: treatment triggers for patients on active surveillance.
Nat Rev Urol. 2011 Mar;8(3):126-7. doi: 10.1038/nrurol.2010.235. Epub 2011 Jan 18.
6
Prostate cancer: surgery versus observation for localized prostate cancer.
Nat Rev Urol. 2014 Jun;11(6):312-3. doi: 10.1038/nrurol.2014.109. Epub 2014 May 13.
7
Reply: To PMID 25283701.
Urology. 2014 Dec;84(6):1262. doi: 10.1016/j.urology.2014.06.066. Epub 2014 Oct 3.
8
Prostate cancer: reducing overtreatment: active surveillance in low-risk disease.
Nat Rev Urol. 2011 Mar;8(3):124-5. doi: 10.1038/nrurol.2011.8. Epub 2011 Feb 8.
9
Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Con.
J Urol. 2017 Nov;198(5):997-999. doi: 10.1016/j.juro.2017.08.088. Epub 2017 Sep 22.
10
Prostate cancer: Active surveillance comes of age.
Nat Rev Urol. 2015 Feb;12(2):62. doi: 10.1038/nrurol.2014.363. Epub 2015 Jan 6.
Zotero 插件